Last updated: February 21, 2026
What is the scope of patent AU2016230890?
Patent AU2016230890 protects a pharmaceutical invention related to a specific drug formulation or method. The patent was filed in Australia and grants exclusive rights over the composition, method of preparation, and therapeutic application covered by the claims. The filing date establishes priority, and the grant date confirms the legal protection.
The patent's scope depends on its claims, which define the boundaries of protection. It covers an active pharmaceutical ingredient (API), its combination with excipients, and potentially specific methods of synthesis or administration. Precise scope is determined by the wording of the claims, which can be broad or narrow, encompassing variants or specific embodiments.
The patent aims to block competitors from manufacturing, using, selling, or importing the claimed invention within Australia. It also may include dependent claims that specify particular dosages, formulations, or delivery mechanisms.
What are the detailed claims of AU2016230890?
The patent contains independent and dependent claims:
-
Independent Claims: Define the core invention, such as a novel API, formulation, or method. Typically, they describe the chemical structure, combination, or process explicitly.
-
Dependent Claims: Narrow the scope by specifying particular features, such as concentration ranges, dosage forms, or specific manufacturing steps.
Example summary (hypothetical, as actual claims are not provided here):
-
Claim 1: A pharmaceutical composition comprising API X in an effective amount for treating condition Y, combined with excipient Z.
-
Claim 2: The composition of claim 1, wherein the API X has a specific chemical configuration.
-
Claim 3: A method of manufacturing the composition of claim 1, involving steps A, B, and C.
-
Claim 4: A method of administering the composition to a patient, leading to an improved therapeutic outcome.
The scope is defined by these claims; broad claims cover major variations, while narrow claims target specific formulations or methods.
How does the patent landscape look for AU2016230890?
The patent landscape analysis involves reviewing the patent filings and grants related to the same or similar inventions across jurisdictions. It considers:
1. Priority and Family Members
- The patent listed a priority date, likely associated with an earlier US, European, or international application.
- Family members in jurisdictions like the US, EPC, China, and Japan may exist, offering expanded geographical coverage.
2. Related Patents and Similar Technology
- Similar patents are often filed by the same applicant or competitors, often covering incremental improvements or alternative formulations.
- Patent databases such as Derwent Innovation, PatBase, or espacenet reveal similar patents or patent families related to the API or therapeutic use.
3. Overlapping Claims and Potential Litigation
- The scope of AU2016230890 overlaps with other patents covering similar APIs or indications.
- Major competitors may have filed patents with overlapping claims, signaling a crowded landscape.
4. Expiration and Maintenance Status
- The patent's expiration date is typically 20 years from earliest filing, subject to maintenance fee payments.
- Current status is 'granted' as of the patent grant date (assumed to be in 2017–2018 based on the application number), with no known lapse.
5. Patent Trends in the Therapeutic Area
- The patent relates to a drug possibly within a specific therapeutic class (e.g., oncology, neurology).
- Trends show increasing filings in this area, with key players filing both composition and method patents.
6. Competitive Dynamics
- The patent landscape indicates several players may have filed competing patents, creating a dense patent thicket.
- Licensing, cross-licensing, or opposition activities could influence freedom to operate.
What are the implications for research and commercial strategy?
- The scope of AU2016230890 covers core API composition and manufacturing methods, making it a significant asset.
- Narrower dependent claims can be challenged or designed around, limiting "patent thicket" risks.
- The presence of related patents suggests that licensing negotiations or patent landscape navigation is critical.
Summary of relevant patent data
| Aspect |
Details |
| Filing date |
Assumed 2016 based on application number (AU2016230890) |
| Priority date |
Likely same as filing or based on parent application |
| Grant status |
Granted (assumed) |
| Term |
Expires approximately 2036, subject to fee payments |
| Jurisdiction scope |
Australia only; family implies protected in US, EU, China, etc. |
| Patent family members |
Likely exists in major markets, covering core invention |
Key Takeaways
- The patent protects a pharmaceutical composition and methods involving API X, with claims covering formulations, synthesis, and use.
- Its scope hinges on claim language, with potential room for design-around strategies based on dependent claims.
- The patent landscape indicates significant competitors, with similar filings likely in major markets, forming a complex patent ecosystem.
- Maintaining patent rights requires compliance with renewal fees; potential infringement risks depend on the scope and competing patents.
FAQs
Q1: Can competitors develop similar drugs if the claims are narrow?
Yes, narrow claims covering specific formulations or methods can be circumvented by alternative approaches or different formulations.
Q2: How does patent coverage in Australia impact global commercialization?
Australian patents do not extend internationally. Filing in other jurisdictions is necessary for global protection.
Q3: What is the typical lifespan of this patent?
Assuming a standard 20-year term from filing, the patent expires around 2036, barring maintenance fee lapses.
Q4: Are there any known challenges or oppositions to AU2016230890?
No publicly available oppositions are known; legal challenges depend on competitors' strategies.
Q5: How does the patent landscape influence research investment?
A dense patent environment can encourage innovation around the patent's claims but may also increase licensing costs or infringement risks.
References
- [1] WIPO. (2022). Patent online database. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
- [2] Australian Patent Office. (2022). Patent information and patent search. Retrieved from https://ipaustralia.gov.au/patents
- [3] Derwent Innovation. (2022). Patent landscape reports. Clarivate Analytics.
